Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124302512 | 12430251 | 2 | F | 201508 | 20160830 | 20160602 | 20160901 | EXP | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-34600BP | BOEHRINGER INGELHEIM | 71.80 | YR | M | Y | 0.00000 | 20160901 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124302512 | 12430251 | 1 | PS | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG | Y | 20579 | .4 | MG | CAPSULE | QD | |||||
| 124302512 | 12430251 | 2 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG | 0 | 10 | MG | QD | |||||||
| 124302512 | 12430251 | 3 | C | methiamazole | 2 | Oral | 5 MG | 0 | 5 | MG | QD | ||||||||
| 124302512 | 12430251 | 4 | C | LORAZEPAM. | LORAZEPAM | 1 | Oral | 3 MG | 0 | 3 | MG | QD | |||||||
| 124302512 | 12430251 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 10 MG | 0 | 10 | MG | QD | |||||||
| 124302512 | 12430251 | 6 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 0 | 18 | UG | INHALATION POWDER, HARD CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124302512 | 12430251 | 1 | Prostatomegaly |
| 124302512 | 12430251 | 2 | Hypertension |
| 124302512 | 12430251 | 3 | Hyperthyroidism |
| 124302512 | 12430251 | 4 | Anxiety |
| 124302512 | 12430251 | 5 | Blood cholesterol increased |
| 124302512 | 12430251 | 6 | Chronic obstructive pulmonary disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124302512 | 12430251 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124302512 | 12430251 | Dizziness | |
| 124302512 | 12430251 | Escherichia infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124302512 | 12430251 | 1 | 201508 | 201510 | 0 | |
| 124302512 | 12430251 | 2 | 2006 | 0 | ||
| 124302512 | 12430251 | 3 | 2006 | 0 | ||
| 124302512 | 12430251 | 4 | 2006 | 0 | ||
| 124302512 | 12430251 | 5 | 2006 | 0 | ||
| 124302512 | 12430251 | 6 | 2006 | 0 |